| Literature DB >> 26889190 |
Bei Zhang1, Qiang He1, Ying-Ying Li1, Ce Li1, Yu-Long Bai1, Yong-Shan Hu2, Feng Zhang3.
Abstract
Motor function impairment is a common outcome of stroke. Constraint-induced movement therapy (CIMT) involving intensive use of the impaired limb while restraining the unaffected limb is widely used to overcome the effects of 'learned non-use' and improve limb function after stroke. However, the underlying mechanism of CIMT remains unclear. In the present study, rats were randomly divided into a middle cerebral artery occlusion (model) group, a CIMT + model (CIMT) group, or a sham group. Restriction of the affected limb by plaster cast was performed in the CIMT and sham groups. Compared with the model group, CIMT significantly improved the forelimb functional performance in rats. By western blot assay, the expression of phosphorylated extracellular regulated protein kinase in the bilateral cortex and hippocampi of cerebral ischemic rats in the CIMT group was significantly lower than that in the model group, and was similar to sham group levels. These data suggest that functional recovery after CIMT may be related to decreased expression of phosphorylated extracellular regulated protein kinase in the bilateral cortex and hippocampi.Entities:
Keywords: NSFC grants; balance beam walking; brain ischemia; constraint-induced movement therapy; cortex; foot fault test; hippocampus; locomotion; middle cerebral artery occlusion; mitogen-activated protein kinase signaling system; nerve regeneration; neural regeneration; rats; recovery
Year: 2015 PMID: 26889190 PMCID: PMC4730826 DOI: 10.4103/1673-5374.172319
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Figure 1A rat with plaster cast on the horizontal ladder.
The rat walked across the horizontal ladder using its affected limb.
Figure 2Effect of constraint-induced movement therapy (CIMT) on body weight of cerebral ischemic rats.
There were five rats per group per time point (one-way analysis of variance and the least significant difference post hoc test). The body weight of the rats decreased significantly in the CIMT group and model group at 7 days after surgery (d7, #P = 0.046, vs. CIMT group; *P = 0.038, vs. model group). However, no significant difference was found among the three groups at 22 days after surgery (d22). n = 5 per group per time point (one-way analysis of variance and the least significant difference post hoc test). d: Day(s).
Effect of CIMT on neurological defect scores of rats with cerebral ischemia
Effect of CIMT on scores of balance beam walking test and proportions (%) of the fault footsteps of cerebral ischemic rats
Figure 3Effect of constraint-induced movement therapy (CIMT) on brain infarct area (white color) of cerebral ischemic rats (2,3,5-triphenyltetrazolium chloride staining).
Figure 4Effect of constraint-induced movement therapy (CIMT) on the expression of extracellular regulated protein kinase (ERK) in the bilateral cortex and hippocampi of cerebral ischemic rats.
Protein expression of total ERK and phosphorylated ERK (p-ERK) in the cortex and hippocampus were obtained by calculating the ratio of the grey value of the bands between ERK and GAPDH or between p-ERK and GAPDH. (A) No significant differences were observed for total ERK protein expression between the groups in the cortex. (B) p-ERK protein expression in the model group was significantly higher than that in the CIMT group and sham group in the bilateral cortex. (C) There were no significant differences in total ERK expression between the groups in the bilateral hippocampi at 22 days after surgery. (D) p-ERK expression in the bilateral hippocampi in model group was significantly higher than that in the CIMT group and sham group. *P < 0.01, vs. model group at same side. Data are expressed as the mean ± SD (n = 5 per group; one-way analysis of variance for comparisons among groups and the least significant difference post hoc test). The molecular weights of ERK1 and ERK2 were 44 kDa and 42 kDa, respectively. DAPDH: Glyceraldehyde 3-phosphate dehydrogenase; L: Left; R: right.